FindTrial
Sign In

Body mass index and medication utilization in migraine

Body mass index and medication utilization in migraine - Body mass index and medication utilization in migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000042202
Enrollment
20000
Registered
2020-10-22
Start date
2020-10-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

None listed

Sponsors

Tominaga Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with standard insurance diagnosis of headache and/or migraine who are prescribed triptans

Exclusion criteria

Exclusion criteria: 1) Patients with standard insurance diagnosis of primary headache disorders except for migraine and/or tension type headache 2) Patients with standard insurance diagnosis of secondary headache disorders except for medication overuse headache 3) Patients with standard insurance diagnosis of painful cranial neuropathies and/or other facial pain and other headaches

Design outcomes

Primary

MeasureTime frame
The used amount of acute and prophylactic medicine in accordance with BMI—

Countries

Japan

Contacts

Public ContactDaisuke DANNO

Tominaga Hospital Headache center, Department of neurology

daisuke_danno@yahoo.co.jp06-6568-1601

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026